Table 2.
Year | Age < 50 Years
|
Age 50-79 Years
|
Age 80+ Years
|
All Patients
|
Weighted‡ Cumulative Incidence | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of New Lymphedema Diagnoses | No. of Participants at Risk at Start of Year* | Cumulative Incidence† | No. of New Lymphedema Diagnoses | No. of Participants at Risk at Start of Year | Cumulative Incidence | No. of New Lymphedema Diagnoses | No. of Participants at Risk at Start of Year | Cumulative Incidence | No. of New Lymphedema Diagnoses | No. of Participants at Risk at Start of Year | Cumulative Incidence | ||
Year 1 | 59 | 196 | 0.31 | 86 | 354 | 0.25 | 15 | 81 | 0.19 | 160 | 631 | 0.26 | 0.25 |
Year 2 | 12 | 124 | 0.38 | 16 | 253 | 0.30 | 3 | 61 | 0.23 | 31 | 440 | 0.31 | 0.30 |
Year 3 | 8 | 102 | 0.43 | 12 | 215 | 0.34 | 0 | 49 | 0.23 | 20 | 366 | 0.36 | 0.34 |
Year 4 | 6 | 82 | 0.47 | 11 | 171 | 0.38 | 0 | 29 | 0.23 | 17 | 282 | 0.40 | 0.38 |
Year 5 | 4 | 74 | 0.50 | 5 | 150 | 0.40 | 1 | 25 | 0.26 | 10 | 249 | 0.42 | 0.41 |
Denominators are reduced by loss to follow-up and by censoring at time of first lymphedema occurrence.
Cumulative incidence using standard survival analysis methods.
Weighted by age distribution of breast cancer population of Philadelphia and Delaware Counties.